Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909608 · ClinicalTrials.gov registry record
Actigraphy in Pediatric Pulmonary Hypertension
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 116
- Enrollment target
NCT02909608: Completed study, sponsored by University of Colorado, Denver.
NCT02909608 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909608 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
Physical activity is an important factor in understanding how diseases can affect a child. Decreases in physical activity are sometimes the first thing that happens before a child is diagnosed with a disease. When a child sees their doctor, that visit reflects a single point in time. It does not capture how a child feels during the days in between visits to their doctor. This study plans to use special monitors called actigraphs to collect information about physical activity in children with a type of disease called pulmonary hypertension. This study will measure how active these children are and compare their activity to clinical information and to actigraphy measurements in children without pulmonary hypertension.
Primary Outcome
Children will wear both actigraphy devices for 2 weeks at 2 different time points. The first time point is at Baseline when the child enters the study. The second time point is at Week 26, which is 26 weeks after the Baseline timepoint.
Interventions
- OTHER No interventions / observations only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2016-10-07 |
| Est. Completion | 2020-04-02 |
What the finished NCT02909608 record still lists
NCT02909608 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No interventions / observations only is the first listed.
NCT02909608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02909608 about?
NCT02909608 is a clinical study titled "Actigraphy in Pediatric Pulmonary Hypertension". Physical activity is an important factor in understanding how diseases can affect a child. Decreases in physical activity are sometimes the first thing that happens before a child is diagnosed with a disease. When a child sees their doctor, that visit reflects a single point in time. It does not cap...
What is the current status of trial NCT02909608?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2016-10-07. Estimated completion is 2020-04-02.
What interventions are being tested in trial NCT02909608?
The interventions under investigation include: No interventions / observations only (OTHER).
Who is sponsoring clinical trial NCT02909608?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI